RecruitingPhase 3NCT05261139
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
Studying Periodontal Ehlers-Danlos syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Pfizer
- Principal Investigator
- Pfizer CT.gov Call CenterPfizer
- Intervention
- nirmatrelvir(drug)
- Enrollment
- 160 enrolled
- Eligibility
- 0-17 years · All sexes
- Timeline
- 2022 – 2026
Study locations (30)
- Phoenix Children's Hospital, Phoenix, Arizona, United States
- Children's Hospital Los Angeles, Los Angeles, California, United States
- Kaiser Permanente, Los Angeles, California, United States
- UCLA David Geffen School of Medicine, Los Angeles, California, United States
- UCLA, Los Angeles, California, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Life Spring Research Foundation, Miami, Florida, United States
- Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta, Georgia, United States
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City, Georgia, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- University of Chicago Medical Center, Chicago, Illinois, United States
- Louisiana State University Health Sciences Shreveport, Shreveport, Louisiana, United States
- Johns Hopkins Hospital, Baltimore, Maryland, United States
- Boston Medical Center, Boston, Massachusetts, United States
- University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05261139 on ClinicalTrials.govOther trials for Periodontal Ehlers-Danlos syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07528547Hypersight and Ethos In Pediatric RadiotherapyUniversity Health Network, Toronto
- RECRUITINGPHASE4NCT06590402Anterior Femoral and Adductor Canal Nerve Blocks in Peds KneesHospital for Special Surgery, New York
- RECRUITINGPHASE3NCT06739122A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)Eli Lilly and Company
- RECRUITINGPHASE4NCT04040452Continuous vs Intermittent Ketorolac for Pain Control in Peds CV SurgeryPhoenix Children's Hospital